Twinbeech Capital LP Abbott Laboratories Transaction History

Twinbeech Capital LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$109.52 - $120.96 $38.6 Million - $42.7 Million	352,692 New	352,692 $40.1 Million
Q2 2023 Aug 14, 2023	BUY	$100.78 - $112.29 $17.1 Million - $19 Million	169,414 Added 101.89%	335,680 $36.6 Million
Q1 2023 May 15, 2023	BUY	$96.86 - $114.01 $14.2 Million - $16.7 Million	146,259 Added 731.04%	166,266 $16.8 Million
Q4 2022 Feb 14, 2023	BUY	$95.06 - $111.52 $1.9 Million - $2.23 Million	20,007 New	20,007 $2.2 Million
Q1 2022 May 16, 2022	SELL	$114.02 - $139.04 $2.29 Million - $2.79 Million	-20,056 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$115.53 - $141.46 $986,972 - $1.21 Million	8,543 Added 74.2%	20,056 $2.82 Million
Q3 2021 Nov 15, 2021	BUY	$116.66 - $129.06 $1.34 Million - $1.49 Million	11,513 New	11,513 $1.36 Million
Q3 2020 Nov 16, 2020	SELL	$91.64 - $111.29 $5.8 Million - $7.04 Million	-63,292 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$76.57 - $98.0 $4.85 Million - $6.2 Million	63,292 New	63,292 $5.79 Million

3,186

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $206B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Twinbeech Capital LP, based on Form 13F filings with the SEC.

Stay updated on Twinbeech Capital LP with notifications on news.